Indaptus Therapeutics (INDP) Prepaid Assets (2020 - 2026)
Indaptus Therapeutics (INDP) posted quarterly Prepaid Assets of $62588.0 for Q1 2026, down 83.29% year-over-year from $374638.0 in Q1 2025, and down 83.97% quarter-over-quarter from $390361.0 in Q4 2025.
Indaptus Therapeutics (INDP) Prepaid Assets (2020 - 2026) Analysis & Trends
Indaptus Therapeutics' Prepaid Assets history runs 7 years deep, the most recent figure standing at $62588.0 for Q1 2026.
- In Q1 2026, Prepaid Assets fell 83.29% year-over-year to $62588.0; the TTM figure through Mar 2026 stood at $62588.0 (down 83.29% YoY), while the FY2025 annual figure was $390361.0, down 22.93% from the prior year.
- Prepaid Assets for Q1 2026 stood at $62588.0, down from $390361.0 in the prior quarter.
- The five-year high for Prepaid Assets was $1.1 million in Q3 2022, with the low at $45896.0 in Q2 2023.
- The 5-year median for Prepaid Assets is $219940.0 (2024), against an average of $342154.6.
- Peak annual rise in Prepaid Assets reached 830.44% in 2022, while the deepest fall reached 93.87% in 2022.
- Indaptus Therapeutics' Prepaid Assets stood at $120315.0 in 2022, then jumped by 426.25% to $633156.0 in 2023, then decreased by 20.01% to $506489.0 in 2024, then dropped by 22.93% to $390361.0 in 2025, then plunged by 83.97% to $62588.0 in 2026.
- Business Quant data shows INDP's Prepaid Assets at $62588.0 in Q1 2026, $390361.0 in Q4 2025, and $613354.0 in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.13 Bn | 131.28 Bn | 2.84 Bn |
| 2 | Regeneron Pharmaceuticals | 85.77 Bn | 77.77 Bn | 3.93 Bn |
| 3 | Argenx Se | 64.64 Bn | 59.46 Bn | 1.37 Bn |
| 4 | Moderna | 58.29 Bn | 53.16 Bn | 52.00 Mn |
| 5 | BeOne Medicines | 41.92 Bn | 36.82 Bn | 1.53 Bn |
| 6 | Alnylam Pharmaceuticals | 31.58 Bn | 28.28 Bn | 992.69 Mn |
| 7 | BioNTech SE | 28.12 Bn | 9.73 Bn | 668.28 Mn |
| 8 | Insmed | 27.39 Bn | 26.22 Bn | 358.27 Mn |
| 9 | Royalty Pharma | 27.27 Bn | 26.43 Bn | - |
| 10 | Indaptus Therapeutics | 146.91 Mn | 135.35 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 434,136.00 |
| Mar 31, 2026 | 62,588.00 |
| Dec 31, 2025 | 390,361.00 |
| Sep 30, 2025 | 613,354.00 |
| Jun 30, 2025 | 83,698.00 |
| Mar 31, 2025 | 374,638.00 |
| Dec 31, 2024 | 506,489.00 |
| Sep 30, 2024 | 219,940.00 |
| Jun 30, 2024 | 93,047.00 |
| Mar 31, 2024 | 551,031.00 |
| Dec 31, 2023 | 633,156.00 |
| Sep 30, 2023 | 122,186.00 |
| Jun 30, 2023 | 45,896.00 |
| Mar 31, 2023 | 75,522.00 |
| Dec 31, 2022 | 120,315.00 |
| Sep 30, 2022 | 1.13 Mn |
| Jun 30, 2022 | 49,070.00 |
| Mar 31, 2022 | 741,945.00 |
| Dec 31, 2021 | 12,931.00 |
| Sep 30, 2021 | 213,190.00 |